Pasithea Therapeutics Corp. (KTTA) analyst actions
Rating and price-target actions on KTTA in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the KTTA overview →
1 measured KTTA analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Pasithea Therapeutics Announces Initiation of Phase 1/1B Study of PAS-004 in Adult NF1 Patients and Activation of First Clinical Trial Site | Press release | +4.88% | +6.13% |
Keep exploring
More KTTA: earnings → · SEC filings → · KTTA overview →